Expectations for Early Diagnosis of Rare Diseases with the Introduction of State-Led 'Newborn Genomic Screening'
The government has recently decided to promote 'genomic screening' for newborns on a national level. The purpose of this initiative is to check the genes of babies shortly after birth to detect rare genetic diseases early and manage them systematically.
For rare genetic diseases, the timing of treatment is crucial. Once this screening program is in full swing, it is expected that early detection will improve treatment outcomes and help children grow up healthy. Furthermore, it is anticipated that the financial burden on families will be significantly reduced.
Meanwhile, the role of regional base hospitals, such as Hongseong Medical Center, is becoming increasingly important. These hospitals perform a core role in safeguarding the health of local communities by providing essential medical services, including infectious disease response, mental health care, and rehabilitation therapy.
Through this newborn genomic screening program, the government plans to strive to ensure that high-quality medical benefits can be received anywhere in the country. We look forward to the successful establishment of this program, creating an environment where more children can grow up healthy.